Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Intra-Cellular Therapies Revenue

Oncoclínicas do Brasil Serviços Médicos had revenue of 1.49B BRL in the quarter ending March 31, 2025, with 2.36% growth. This brings the company's revenue in the last twelve months to 6.26B, up 10.75% year-over-year. In the year 2024, Oncoclínicas do Brasil Serviços Médicos had annual revenue of 6.23B with 13.45% growth.

• Revenue (ttm): 6.26B
• Revenue Growth: +10.75%
• P/S Ratio: 0.55
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.23B	738.45M	13.45%
Dec 31, 2023	5.49B	1.40B	34.26%
Dec 31, 2022	4.09B	1.39B	51.30%
Dec 31, 2021	2.70B	666.88M	32.77%
Dec 31, 2020	2.04B	345.68M	20.46%